chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death, Delirium, Fatigue, Gastrointestinal stoma complication, Hyperkalaemia
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/14/2021, 1/31/2021 and 12/27/2021. Presented to ED 2/4/2022 c/o generalized weakness, fatigue, and high output from his ostomy. Admitted for septic shock, acute cycstitis, Covid19 requiring O2. Course c/b AKI w/azotemia, hperkalemia, metabolic acidosis and acute metabolic encephalopathy delirium. Tx'd w/decadron and Tylenol. Transitioned to comfort care instituted and expired 2/17/22.
Age: 82.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic acidosis, Metabolic encephalopathy, SARS-CoV-2 test positive, Septic shock
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 1/14/2021, 1/31/2021 and 12/27/2021. Presented to ED 2/4/2022 c/o generalized weakness, fatigue, and high output from his ostomy. Admitted for septic shock, acute cycstitis, Covid19 requiring O2. Course c/b AKI w/azotemia, hperkalemia, metabolic acidosis and acute metabolic encephalopathy delirium. Tx'd w/decadron and Tylenol. Transitioned to comfort care instituted and expired 2/17/22.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Chills, Computerised tomogram head normal
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccines on 1/26/2021, 2/20/2021 and 1/17/2022. Presented to ED 2/8/2022 w/AMS, along with cough, fever, chills, fatigue and weakness. Diagnosed with COVID-19 on 1/31/2022 and since that time had decreased activity level. CTH in the ED was negative. Admitted for sepsis w/encephalopathy with septic shock, unspecified organism. Over the hospitalization patient required increasing supplemental oxygen, developed AKI, and lactic acidosis. Elected for comfort measures on 2/19/2022 and expired.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Cough, Death, Decreased activity, Encephalopathy, Fatigue
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccines on 1/26/2021, 2/20/2021 and 1/17/2022. Presented to ED 2/8/2022 w/AMS, along with cough, fever, chills, fatigue and weakness. Diagnosed with COVID-19 on 1/31/2022 and since that time had decreased activity level. CTH in the ED was negative. Admitted for sepsis w/encephalopathy with septic shock, unspecified organism. Over the hospitalization patient required increasing supplemental oxygen, developed AKI, and lactic acidosis. Elected for comfort measures on 2/19/2022 and expired.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Inappropriate schedule of product administration, Lactic acidosis, Mental status changes, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccines on 1/26/2021, 2/20/2021 and 1/17/2022. Presented to ED 2/8/2022 w/AMS, along with cough, fever, chills, fatigue and weakness. Diagnosed with COVID-19 on 1/31/2022 and since that time had decreased activity level. CTH in the ED was negative. Admitted for sepsis w/encephalopathy with septic shock, unspecified organism. Over the hospitalization patient required increasing supplemental oxygen, developed AKI, and lactic acidosis. Elected for comfort measures on 2/19/2022 and expired.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sepsis, Septic shock
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Received Pfizer Vaccines on 1/26/2021, 2/20/2021 and 1/17/2022. Presented to ED 2/8/2022 w/AMS, along with cough, fever, chills, fatigue and weakness. Diagnosed with COVID-19 on 1/31/2022 and since that time had decreased activity level. CTH in the ED was negative. Admitted for sepsis w/encephalopathy with septic shock, unspecified organism. Over the hospitalization patient required increasing supplemental oxygen, developed AKI, and lactic acidosis. Elected for comfort measures on 2/19/2022 and expired.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Back pain, COVID-19, Cardio-respiratory arrest, Chest X-ray abnormal
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/03/21, 3/03/2021 and 11/27/2021. Covid19 + 2/07/22. Presented to ED 2/11/22 c/o generalized weakness fever, back pain and leg pain both legs worse on the R leg with swelling and redness on the R leg as well, denies any trauma to the legs, she had a fever at home. Admitted Covid infx, R leg pain and abnormaol troponin.. CXR w/some left basal opacity. In the ER BP 151/84 with pulse of 111, the last pulse rate prior to the event was 94. INR was 1.2. Due to increasing swelling on the leg stat CT requested w/DIC labs. At the same time started having AMS, taken for stat brain CT. On arrival back to floor  patient was unresponsive and code blue was initiated, Treated with rocephin and steroids. Pt expired 02/11/22.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, Computerised tomogram head, Death, Erythema, Inappropriate schedule of product administration
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/03/21, 3/03/2021 and 11/27/2021. Covid19 + 2/07/22. Presented to ED 2/11/22 c/o generalized weakness fever, back pain and leg pain both legs worse on the R leg with swelling and redness on the R leg as well, denies any trauma to the legs, she had a fever at home. Admitted Covid infx, R leg pain and abnormaol troponin.. CXR w/some left basal opacity. In the ER BP 151/84 with pulse of 111, the last pulse rate prior to the event was 94. INR was 1.2. Due to increasing swelling on the leg stat CT requested w/DIC labs. At the same time started having AMS, taken for stat brain CT. On arrival back to floor  patient was unresponsive and code blue was initiated, Treated with rocephin and steroids. Pt expired 02/11/22.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: International normalised ratio increased, Laboratory test, Lung opacity, Mental status changes, Pain in extremity
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/03/21, 3/03/2021 and 11/27/2021. Covid19 + 2/07/22. Presented to ED 2/11/22 c/o generalized weakness fever, back pain and leg pain both legs worse on the R leg with swelling and redness on the R leg as well, denies any trauma to the legs, she had a fever at home. Admitted Covid infx, R leg pain and abnormaol troponin.. CXR w/some left basal opacity. In the ER BP 151/84 with pulse of 111, the last pulse rate prior to the event was 94. INR was 1.2. Due to increasing swelling on the leg stat CT requested w/DIC labs. At the same time started having AMS, taken for stat brain CT. On arrival back to floor  patient was unresponsive and code blue was initiated, Treated with rocephin and steroids. Pt expired 02/11/22.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Peripheral swelling, Pyrexia, SARS-CoV-2 test positive, Troponin abnormal, Unresponsive to stimuli
Clinical narrative: Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/03/21, 3/03/2021 and 11/27/2021. Covid19 + 2/07/22. Presented to ED 2/11/22 c/o generalized weakness fever, back pain and leg pain both legs worse on the R leg with swelling and redness on the R leg as well, denies any trauma to the legs, she had a fever at home. Admitted Covid infx, R leg pain and abnormaol troponin.. CXR w/some left basal opacity. In the ER BP 151/84 with pulse of 111, the last pulse rate prior to the event was 94. INR was 1.2. Due to increasing swelling on the leg stat CT requested w/DIC labs. At the same time started having AMS, taken for stat brain CT. On arrival back to floor  patient was unresponsive and code blue was initiated, Treated with rocephin and steroids. Pt expired 02/11/22.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine normal, Blood sodium normal, Cerebral mass effect, Computerised tomogram head abnormal, Endotracheal intubation
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Life Threatening Illness. Received Moderna Vaccine on 12/21/2021. Admitted from outside facility to ICU for acute intracranial hemorrhage and suspected immune thrombocytopenia. Presented to outside facility ED c/o HA and sinus pain, acutely developed facial droop and left sided weakness. Stat CT with evidence of intracranial hemorrhage with midline shift. Began vomiting, intubated for airway protection. Initial lab work was significant for platelet count of 1, Hgb 11, Na 140, creatinine 0.8. Received the following interventions: hypertonic saline, mannitol, steroids, and nicardipine drip. Transferred  for higher level of care. Trach placed 1/31/22.   Continued to improve neurologically. Sodium goals were relaxed to normonatremia and neuro checkls relaxed to q4 with q12 sodium checks and transferred to the floor on 02/20/22 with d/c plan to rehab facility.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Facial paralysis, Haemoglobin decreased, Haemorrhage intracranial, Headache, Hemiparesis
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Life Threatening Illness. Received Moderna Vaccine on 12/21/2021. Admitted from outside facility to ICU for acute intracranial hemorrhage and suspected immune thrombocytopenia. Presented to outside facility ED c/o HA and sinus pain, acutely developed facial droop and left sided weakness. Stat CT with evidence of intracranial hemorrhage with midline shift. Began vomiting, intubated for airway protection. Initial lab work was significant for platelet count of 1, Hgb 11, Na 140, creatinine 0.8. Received the following interventions: hypertonic saline, mannitol, steroids, and nicardipine drip. Transferred  for higher level of care. Trach placed 1/31/22.   Continued to improve neurologically. Sodium goals were relaxed to normonatremia and neuro checkls relaxed to q4 with q12 sodium checks and transferred to the floor on 02/20/22 with d/c plan to rehab facility.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Immune thrombocytopenia, Intensive care, Platelet count decreased, Sinus pain, Tracheostomy
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Life Threatening Illness. Received Moderna Vaccine on 12/21/2021. Admitted from outside facility to ICU for acute intracranial hemorrhage and suspected immune thrombocytopenia. Presented to outside facility ED c/o HA and sinus pain, acutely developed facial droop and left sided weakness. Stat CT with evidence of intracranial hemorrhage with midline shift. Began vomiting, intubated for airway protection. Initial lab work was significant for platelet count of 1, Hgb 11, Na 140, creatinine 0.8. Received the following interventions: hypertonic saline, mannitol, steroids, and nicardipine drip. Transferred  for higher level of care. Trach placed 1/31/22.   Continued to improve neurologically. Sodium goals were relaxed to normonatremia and neuro checkls relaxed to q4 with q12 sodium checks and transferred to the floor on 02/20/22 with d/c plan to rehab facility.
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Moderna COVID Vaccine EUA: COVID-19 case resulting in Life Threatening Illness. Received Moderna Vaccine on 12/21/2021. Admitted from outside facility to ICU for acute intracranial hemorrhage and suspected immune thrombocytopenia. Presented to outside facility ED c/o HA and sinus pain, acutely developed facial droop and left sided weakness. Stat CT with evidence of intracranial hemorrhage with midline shift. Began vomiting, intubated for airway protection. Initial lab work was significant for platelet count of 1, Hgb 11, Na 140, creatinine 0.8. Received the following interventions: hypertonic saline, mannitol, steroids, and nicardipine drip. Transferred  for higher level of care. Trach placed 1/31/22.   Continued to improve neurologically. Sodium goals were relaxed to normonatremia and neuro checkls relaxed to q4 with q12 sodium checks and transferred to the floor on 02/20/22 with d/c plan to rehab facility.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Diarrhoea, Electrocardiogram, Heart rate irregular
Clinical narrative: Irregular heartbeat beginning around 7:45 PM 02/16/2022 First sign of Atrial Fibrillation at 9:40 PM 02/16/2022 Continued irregular heart beat and either inconclusive ECG and intermittent Atrial Fibrillation continued until 8:00 am 02/18/2022  Irregular heartbeat returned with inconclusive ECG at 10:00 PM 02/18/2022 and continued until 8:45 PM 02/19/2022  Diarrhea began at 07:15 am 08/17/2022 and continued until 8:30 am 02/19/2022
Age: 51.0
Sex: F
Vaccine: UNK
Symptoms: Tuberculin test negative, Wrong product administered
Clinical narrative: Patient was given a TB skin test when she was actually suppose to get a Tdap vaccine. Patient did not have any reactions to the TB skin test. Patient was notified of the mistake and given the Tdap vaccine.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Had a breakthrough of COVID after being fully vaccinated.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Decreased appetite, Diarrhoea, Eructation, General physical health deterioration
Clinical narrative: Continuous Eructation and Singultus onset within 2 hours of vaccination on 2/17, loss of appetite and lethargy with continued unabated eructation and singultus 2/18.  Patient anxiety due to worsening condition, 2/19, visit to Dr. diagnosed Mesenteric Lymphadenitis. Continuous Eructation and Singultus on 2/19-present Vomiting on 2/20. Loose Stools on 2/21
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Hiccups, Lethargy, Lymphadenitis, Vomiting
Clinical narrative: Continuous Eructation and Singultus onset within 2 hours of vaccination on 2/17, loss of appetite and lethargy with continued unabated eructation and singultus 2/18.  Patient anxiety due to worsening condition, 2/19, visit to Dr. diagnosed Mesenteric Lymphadenitis. Continuous Eructation and Singultus on 2/19-present Vomiting on 2/20. Loose Stools on 2/21
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT WAS ADMINISTERED EXPIRED PFIZER COVID BOOSTER PER POLICY. PER PFIZER THE VACCINE HAS A 15 DAY GRACE PERIOD AFTER THE 30 DAYS OF BEING OUT OF THE FREEZER. VACCINE WAS STILL WITHIN THE TIME FRAME OF BEING GIVEN.   AFTER NOTIFICATION DR. CALLED PATIENT AND EXPLAINED THE SITUATION AND MADE SURE THE PATIENT DIDN'T HAVE ANY QUESTIONS OR CONCERNS.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram, Loss of consciousness, Vomiting
Clinical narrative: Patient lost conciseness briefly, and vomited post COVID-19 booster
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Fatigue, Headache, Pain in extremity
Clinical narrative: Pain in arm of injection site, stomach cramps, headache, severe fatigue
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: no symptoms noted
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse effect. Vaccine stored incorrectly at -20 Celsius making vaccine invalid
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Expired product administered, No adverse event
Clinical narrative: Child was vaccinated with expired vaccine, I was instructed by Department to fill out VEARS report. Child did not have any adverse reaction and did not need treatment.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive
Clinical narrative: Pt is approximately 5 weeks pregnant with ectopic pregnancy and was vaccinated for covid. Pt admitted for ectopic pregnancy and was covid positive
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Vaccine stored incorrectly at -20 Celsius. No valid vaccine administered-no adverse effects
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: About 7 days after receiving Moderna Booster dosage og .25mg, notice extreme itching, welps and hives on torso, legs and bilateral arms starting around 6:00 pm.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Mouth ulceration
Clinical narrative: I had a mouth ulcer a day after vaccine, It stayed a day or 2. I went to see my doctor, which he prescribed me some Valtrex.  It took at least 3 weeks until I seen a difference.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer Vaccine for 5-11 has a beyond use date of 10 weeks once it is removed from Ultra Low Storage.  This patient was administered a dose that was out of Ultra Low Storage and stored in the refrigerator.  The vial used to delivery the dose had been in the fridge for approximately 11 weeks so the dose administered was one week past the beyond use date.  The patient did not experience any adverse outcomes.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Pfizer Vaccine for 5-11 has a beyond use date of 10 weeks once it is removed from Ultra Low Storage.  This patient was administered a dose that was out of Ultra Low Storage and stored in the refrigerator.  The vial used to delivery the dose had been in the fridge for approximately 11 weeks so the dose administered was one week past the beyond use date.  The patient did not experience any adverse outcomes.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Electrocardiogram normal, Laboratory test, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID on 01/30/2022. Starting 02/03/2022, I experienced sustained tachycardia at a rate of about 160 bpm. I was light headed, feeling like I could pass out and couldn't stand up. I had a friend take me to Urgent Care, who upon looking at me and my HR, sent me to the Hospital ER. Lab work came back normal and EKG was normal (hours later) so they referred me to see my PCP who referred me to a cardiologist (have an appointment tomorrow 02/25/2022)
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Moderna booster of 0.25 mL that resulted in this visit. Pt previously required observational stay after 2nd dose of Pfizer COVID-19 vaccine in June 2021. Now pt is admitted after reaction to Moderna COVID-19 booster dose. Pt woke up following morning with hives. Pt was given  epinephrine, benadryl, and dexamethasone.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain
Clinical narrative: muscle pain in upper part of right arm (same arm as injection) pain is decreasing over time but not gone
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Patient vaccinated against and then tested positive for COVID19
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Abdominal wall haematoma, Ascites, Asthenia, Blood creatinine increased
Clinical narrative: "The patient is a 73 y.o. female, presented on 2/14/2022 with the above. The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include fatigue . Alleviated by none. The patient has a history of pericardial effusion and afib for which she is on warfarin. She also has a history of GI bleed and had an EGD on 8/4/21 with ablation of gastric AVM's. She had a C.scope on 1/27/22 with poor prep but a polyp was noted in the transverse colon and she had some diverticulosis. The patient states that she has had some shortness of breath and weakness for several days. She was seen here on the 10th and was found to be covid 19 positive. She was discharged for outpatient management. Since that time she states that she has felt worse and she has noted melena when she uses the bathroom. She came back to the ED today and was noted to have a Sodium of 124 with a cr of 1.4 and a serum osmolality of 256. She also had  A hemoglobin of 6.4 and an INR of 6.9.her hemoglobin on the 10th was 10.6.  She deneis any bright red blood per rectum. She has had some pain in her abdomen to touch on the left side of her abdomen. CT of the abdomen pelvis showed a subacute hematoma in the rectus sheath. She was also noted to have a dilated IVC and ascities. The patient is currently on 3 liters. She states that she is on 3 liters at home. She has been admitted for further management."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute blood loss anemia o Acute blood loss anemia. Upper endoscopy done showing hiatal hernia and chronic gastritis with no evidence of any active GI bleeding.  Hgb 7.7 today, remains stable/unchanged. She will need further GI evaluation on outpatient basis. Follow-up with GI. Discharge home today with home health. Patient changed her mind and does not want inpatient rehabilitation. o COVID-19 virus infection. Remdesivir course done. Remains on 3 L of oxygen by nasal cannula. Continue to monitor. o INR was elevated on admission. Coumadin was held due to acute blood loss anemia. Needed to vitamin K. INR is trending down. Continue to hold Coumadin and resume when cleared by cardiology and GI. o Atrial fibrillation. Controlled. Continue current treatment and monitor on telemetry. o Anasarca. Controlled on oral diuretics.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Physical deconditioning. Patient changed her mind and does not want inpatient rehabilitation. Discharge home with home health.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood loss anaemia, Blood osmolarity decreased, Blood sodium decreased, COVID-19, Cardiac telemetry
Clinical narrative: "The patient is a 73 y.o. female, presented on 2/14/2022 with the above. The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include fatigue . Alleviated by none. The patient has a history of pericardial effusion and afib for which she is on warfarin. She also has a history of GI bleed and had an EGD on 8/4/21 with ablation of gastric AVM's. She had a C.scope on 1/27/22 with poor prep but a polyp was noted in the transverse colon and she had some diverticulosis. The patient states that she has had some shortness of breath and weakness for several days. She was seen here on the 10th and was found to be covid 19 positive. She was discharged for outpatient management. Since that time she states that she has felt worse and she has noted melena when she uses the bathroom. She came back to the ED today and was noted to have a Sodium of 124 with a cr of 1.4 and a serum osmolality of 256. She also had  A hemoglobin of 6.4 and an INR of 6.9.her hemoglobin on the 10th was 10.6.  She deneis any bright red blood per rectum. She has had some pain in her abdomen to touch on the left side of her abdomen. CT of the abdomen pelvis showed a subacute hematoma in the rectus sheath. She was also noted to have a dilated IVC and ascities. The patient is currently on 3 liters. She states that she is on 3 liters at home. She has been admitted for further management."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute blood loss anemia o Acute blood loss anemia. Upper endoscopy done showing hiatal hernia and chronic gastritis with no evidence of any active GI bleeding.  Hgb 7.7 today, remains stable/unchanged. She will need further GI evaluation on outpatient basis. Follow-up with GI. Discharge home today with home health. Patient changed her mind and does not want inpatient rehabilitation. o COVID-19 virus infection. Remdesivir course done. Remains on 3 L of oxygen by nasal cannula. Continue to monitor. o INR was elevated on admission. Coumadin was held due to acute blood loss anemia. Needed to vitamin K. INR is trending down. Continue to hold Coumadin and resume when cleared by cardiology and GI. o Atrial fibrillation. Controlled. Continue current treatment and monitor on telemetry. o Anasarca. Controlled on oral diuretics.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Physical deconditioning. Patient changed her mind and does not want inpatient rehabilitation. Discharge home with home health.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic gastritis, Colonoscopy abnormal, Computerised tomogram abdomen abnormal, Diverticulum, Dyspnoea
Clinical narrative: "The patient is a 73 y.o. female, presented on 2/14/2022 with the above. The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include fatigue . Alleviated by none. The patient has a history of pericardial effusion and afib for which she is on warfarin. She also has a history of GI bleed and had an EGD on 8/4/21 with ablation of gastric AVM's. She had a C.scope on 1/27/22 with poor prep but a polyp was noted in the transverse colon and she had some diverticulosis. The patient states that she has had some shortness of breath and weakness for several days. She was seen here on the 10th and was found to be covid 19 positive. She was discharged for outpatient management. Since that time she states that she has felt worse and she has noted melena when she uses the bathroom. She came back to the ED today and was noted to have a Sodium of 124 with a cr of 1.4 and a serum osmolality of 256. She also had  A hemoglobin of 6.4 and an INR of 6.9.her hemoglobin on the 10th was 10.6.  She deneis any bright red blood per rectum. She has had some pain in her abdomen to touch on the left side of her abdomen. CT of the abdomen pelvis showed a subacute hematoma in the rectus sheath. She was also noted to have a dilated IVC and ascities. The patient is currently on 3 liters. She states that she is on 3 liters at home. She has been admitted for further management."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute blood loss anemia o Acute blood loss anemia. Upper endoscopy done showing hiatal hernia and chronic gastritis with no evidence of any active GI bleeding.  Hgb 7.7 today, remains stable/unchanged. She will need further GI evaluation on outpatient basis. Follow-up with GI. Discharge home today with home health. Patient changed her mind and does not want inpatient rehabilitation. o COVID-19 virus infection. Remdesivir course done. Remains on 3 L of oxygen by nasal cannula. Continue to monitor. o INR was elevated on admission. Coumadin was held due to acute blood loss anemia. Needed to vitamin K. INR is trending down. Continue to hold Coumadin and resume when cleared by cardiology and GI. o Atrial fibrillation. Controlled. Continue current treatment and monitor on telemetry. o Anasarca. Controlled on oral diuretics.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Physical deconditioning. Patient changed her mind and does not want inpatient rehabilitation. Discharge home with home health.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Endoscopy upper gastrointestinal tract abnormal, Fatigue, Feeling abnormal, Gastrointestinal arteriovenous malformation, Generalised oedema
Clinical narrative: "The patient is a 73 y.o. female, presented on 2/14/2022 with the above. The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include fatigue . Alleviated by none. The patient has a history of pericardial effusion and afib for which she is on warfarin. She also has a history of GI bleed and had an EGD on 8/4/21 with ablation of gastric AVM's. She had a C.scope on 1/27/22 with poor prep but a polyp was noted in the transverse colon and she had some diverticulosis. The patient states that she has had some shortness of breath and weakness for several days. She was seen here on the 10th and was found to be covid 19 positive. She was discharged for outpatient management. Since that time she states that she has felt worse and she has noted melena when she uses the bathroom. She came back to the ED today and was noted to have a Sodium of 124 with a cr of 1.4 and a serum osmolality of 256. She also had  A hemoglobin of 6.4 and an INR of 6.9.her hemoglobin on the 10th was 10.6.  She deneis any bright red blood per rectum. She has had some pain in her abdomen to touch on the left side of her abdomen. CT of the abdomen pelvis showed a subacute hematoma in the rectus sheath. She was also noted to have a dilated IVC and ascities. The patient is currently on 3 liters. She states that she is on 3 liters at home. She has been admitted for further management."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute blood loss anemia o Acute blood loss anemia. Upper endoscopy done showing hiatal hernia and chronic gastritis with no evidence of any active GI bleeding.  Hgb 7.7 today, remains stable/unchanged. She will need further GI evaluation on outpatient basis. Follow-up with GI. Discharge home today with home health. Patient changed her mind and does not want inpatient rehabilitation. o COVID-19 virus infection. Remdesivir course done. Remains on 3 L of oxygen by nasal cannula. Continue to monitor. o INR was elevated on admission. Coumadin was held due to acute blood loss anemia. Needed to vitamin K. INR is trending down. Continue to hold Coumadin and resume when cleared by cardiology and GI. o Atrial fibrillation. Controlled. Continue current treatment and monitor on telemetry. o Anasarca. Controlled on oral diuretics.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Physical deconditioning. Patient changed her mind and does not want inpatient rehabilitation. Discharge home with home health.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hiatus hernia, High frequency ablation, Inferior vena cava dilatation, International normalised ratio increased
Clinical narrative: "The patient is a 73 y.o. female, presented on 2/14/2022 with the above. The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include fatigue . Alleviated by none. The patient has a history of pericardial effusion and afib for which she is on warfarin. She also has a history of GI bleed and had an EGD on 8/4/21 with ablation of gastric AVM's. She had a C.scope on 1/27/22 with poor prep but a polyp was noted in the transverse colon and she had some diverticulosis. The patient states that she has had some shortness of breath and weakness for several days. She was seen here on the 10th and was found to be covid 19 positive. She was discharged for outpatient management. Since that time she states that she has felt worse and she has noted melena when she uses the bathroom. She came back to the ED today and was noted to have a Sodium of 124 with a cr of 1.4 and a serum osmolality of 256. She also had  A hemoglobin of 6.4 and an INR of 6.9.her hemoglobin on the 10th was 10.6.  She deneis any bright red blood per rectum. She has had some pain in her abdomen to touch on the left side of her abdomen. CT of the abdomen pelvis showed a subacute hematoma in the rectus sheath. She was also noted to have a dilated IVC and ascities. The patient is currently on 3 liters. She states that she is on 3 liters at home. She has been admitted for further management."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute blood loss anemia o Acute blood loss anemia. Upper endoscopy done showing hiatal hernia and chronic gastritis with no evidence of any active GI bleeding.  Hgb 7.7 today, remains stable/unchanged. She will need further GI evaluation on outpatient basis. Follow-up with GI. Discharge home today with home health. Patient changed her mind and does not want inpatient rehabilitation. o COVID-19 virus infection. Remdesivir course done. Remains on 3 L of oxygen by nasal cannula. Continue to monitor. o INR was elevated on admission. Coumadin was held due to acute blood loss anemia. Needed to vitamin K. INR is trending down. Continue to hold Coumadin and resume when cleared by cardiology and GI. o Atrial fibrillation. Controlled. Continue current treatment and monitor on telemetry. o Anasarca. Controlled on oral diuretics.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Physical deconditioning. Patient changed her mind and does not want inpatient rehabilitation. Discharge home with home health.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Large intestine polyp, Melaena, Physical deconditioning, SARS-CoV-2 test positive
Clinical narrative: "The patient is a 73 y.o. female, presented on 2/14/2022 with the above. The symptoms/labs were thought to be marked in severity and unstable. Onset several days ago. Associated symptoms include fatigue . Alleviated by none. The patient has a history of pericardial effusion and afib for which she is on warfarin. She also has a history of GI bleed and had an EGD on 8/4/21 with ablation of gastric AVM's. She had a C.scope on 1/27/22 with poor prep but a polyp was noted in the transverse colon and she had some diverticulosis. The patient states that she has had some shortness of breath and weakness for several days. She was seen here on the 10th and was found to be covid 19 positive. She was discharged for outpatient management. Since that time she states that she has felt worse and she has noted melena when she uses the bathroom. She came back to the ED today and was noted to have a Sodium of 124 with a cr of 1.4 and a serum osmolality of 256. She also had  A hemoglobin of 6.4 and an INR of 6.9.her hemoglobin on the 10th was 10.6.  She deneis any bright red blood per rectum. She has had some pain in her abdomen to touch on the left side of her abdomen. CT of the abdomen pelvis showed a subacute hematoma in the rectus sheath. She was also noted to have a dilated IVC and ascities. The patient is currently on 3 liters. She states that she is on 3 liters at home. She has been admitted for further management."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute blood loss anemia o Acute blood loss anemia. Upper endoscopy done showing hiatal hernia and chronic gastritis with no evidence of any active GI bleeding.  Hgb 7.7 today, remains stable/unchanged. She will need further GI evaluation on outpatient basis. Follow-up with GI. Discharge home today with home health. Patient changed her mind and does not want inpatient rehabilitation. o COVID-19 virus infection. Remdesivir course done. Remains on 3 L of oxygen by nasal cannula. Continue to monitor. o INR was elevated on admission. Coumadin was held due to acute blood loss anemia. Needed to vitamin K. INR is trending down. Continue to hold Coumadin and resume when cleared by cardiology and GI. o Atrial fibrillation. Controlled. Continue current treatment and monitor on telemetry. o Anasarca. Controlled on oral diuretics.  o Diabetes mellitus type 2. Continue with same home regimen/equivalent. Monitor blood sugar and cover with insulin sliding scale. o Hypertension. Controlled. Continue same treatment. Follow up daily labs.  o Physical deconditioning. Patient changed her mind and does not want inpatient rehabilitation. Discharge home with home health.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram ambulatory
Clinical narrative: Holter monitor. Cardiology visit within 6 weeks of receiving the COVID vaccine.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Vaccinated pt admitted to inpatient facility
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Computerised tomogram head abnormal, Diplopia, Dizziness, Magnetic resonance imaging head abnormal
Clinical narrative: Hospitalized for TIA. Loss of speech, double vision and extreme dizziness.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: Hospitalized for TIA. Loss of speech, double vision and extreme dizziness.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Rash
Clinical narrative: Patient reports she developed swelling and redness to the injection site soon after her vaccine, which then became a full-body rash. today she is complaining of increased swelling, redness, and pain to the injection site that is spreading up past her shoulder and into the axilla.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Appendicectomy, Appendicitis, Computerised tomogram abdomen abnormal, Drain placement
Clinical narrative: CT scan of the abdomen and pelvis revealed appendicitis with associated fat stranding. She was started on IV Zosyn and was transferred to hospital for further care. She underwent attempted laparoscopic appendectomy with conversion to open appendectomy.  A JP drain was placed in the OR. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic sinusitis, Computerised tomogram abnormal, Dizziness, Dyspnoea, Electrocardiogram
Clinical narrative: I've had intermittent dizziness, nausea, shortness of breath and alternating numbness and tingling in my hands, feet and legs. These symptoms appeared on February 15, 2022, exactly 12 hours after receiving a Pfizer booster shot and were severe enough that I sought treatment at local hospital.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Nausea, Paraesthesia, Pleural thickening, Sinus rhythm
Clinical narrative: I've had intermittent dizziness, nausea, shortness of breath and alternating numbness and tingling in my hands, feet and legs. These symptoms appeared on February 15, 2022, exactly 12 hours after receiving a Pfizer booster shot and were severe enough that I sought treatment at local hospital.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Antibody test negative, Anticoagulant therapy, Chest X-ray, Chest discomfort, Dyspnoea
Clinical narrative: I started experiencing shortness of breathe and chest tightness. My doctor sent me for some additional testing and was later sent to the hospital for a blood clot in my lungs. I stayed in the hospital 2/18-2/21 and I am currently on blood thinners for 6 months.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary thrombosis, SARS-CoV-2 test negative
Clinical narrative: I started experiencing shortness of breathe and chest tightness. My doctor sent me for some additional testing and was later sent to the hospital for a blood clot in my lungs. I stayed in the hospital 2/18-2/21 and I am currently on blood thinners for 6 months.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Gestational diabetes, Induced labour, Pre-eclampsia
Clinical narrative: Found out I was pregnant inbetween the first 2 doses. Developed gestational diabetes at 28 weeks with no prior family history of diabetes and no risk factors. Suddenly developed preeclampsia at 34 weeks and needed to be induced to delivery. Baby boy spent 22 days in NICU
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine was stored in freezer too long resulting in a temperature excursion.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Pain in extremity, Peripheral swelling, Tenderness
Clinical narrative: severe pain in right arm cant move it even painful to touch and right hand swelling
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Dizziness, Loss of consciousness, Nausea, Presyncope
Clinical narrative: Post COVID vaccination vasovagal  episode witnessed by mother and clinic staff. Client sitting in post vaccination area and lost consciousness after saying he felt nausea and dizziness. Immediate return to A&Ox4. walked with assist to wheelchair and rested in stretcher area. discharged home. bp 128/72, hr 64 POX 98%. -RN MD assessment: pt had 5-6 seconds of tonic/clonic activity with amnesia. Able to assist to the floor without trauma. Pt cleared quickly without restriction. advised to follow up with peds or family PCP-MD.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Tonic clonic movements
Clinical narrative: Post COVID vaccination vasovagal  episode witnessed by mother and clinic staff. Client sitting in post vaccination area and lost consciousness after saying he felt nausea and dizziness. Immediate return to A&Ox4. walked with assist to wheelchair and rested in stretcher area. discharged home. bp 128/72, hr 64 POX 98%. -RN MD assessment: pt had 5-6 seconds of tonic/clonic activity with amnesia. Able to assist to the floor without trauma. Pt cleared quickly without restriction. advised to follow up with peds or family PCP-MD.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anaemia, Angiogram pulmonary abnormal, Aspiration pleural cavity, Atrophy
Clinical narrative: a 62 y.o. female with a history of shortness of breath and cough has been present for about the last week. Patient states she's felt that for approximately 2 years atrophy diagnosis stage IV lung cancer she states over last week she's had an increased amount of cough congestion short of breath normally wears 2 L at home but has had to turn it up due to shortness of breath has had a lot of wheezing using breathing treatments at home without success cough will not clear she's had no nausea no vomiting but appetite and decreased she has had about a 60 pound weight loss over last 6 months. Denies chest pain bowels have moved without diarrhea patient seen in emergency room noted have bacterial pneumonia as well as Covid pneumonia. Patient follows with oncology for stage IV lung cancer on immunotherapy.  Patient requests dnr code status".   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute on chronic respiratory failure with hypoxia Description of the Problem/Progression:  Plan:  o Pneumonia due to Covid 19 virus with acute respiratory failure with hypoxia. Improving on current treatment. Completed Remdesivir course D5/5.  Continues on IV Solu-Medrol, transitioned to PO tapering course of Prednisone. Weaned oxygen back to oxygen baseline at 2 L. Will taper Decadron to ONCE DAILY. Nebs and inhalers as ordered. Continue to follow up daily inflammatory markers and d-dimer. Continue nebs and inhalers. Encourage incentive spirometry use and pronating. Continue supportive/symptomatic treatment and supplements as ordered per COVID protocol. Follow up daily lab.  o Strep pneumonia bacteremia. Followed by infectious diseases, consult appreciated. Remains on Rocephin. Repeat blood cultures remained no growth at 96 hours. Sputum culture is pending, patient is unable to produce. Status post pleural tap with only 4 cc retrieved. o COPD with acute exacerbation. Improved. Continue nebs, and inhalers, and weaned off IV Solu-Medrol per above. o Pleural effusion. Interventional radiology consulted for possible pleural tap. o Elevated d-dimer. Repeat CTA of the chest shows no pulmonary embolus. However there is evidence of possible spleen hematoma versus other etiologies. Patient is also anemic. Concern about possible splenic hemorrhage versus infarct. Holding anticoagulation. Switched to SCDs for DVT prophylaxis. General surgery consulted. CT of the abdomen and pelvis ordered with IV contrast showing splenic infarct in addition to worsening omental metastasis. Pulmonary consulted palliative care. Patient requested hospice evaluation. She requested discharge home with hospice.   o Anemia with positive occult blood. Workup otherwise is unremarkable for any B12, iron or folate deficiencies. GI consulted. Endoscopy only with overt bleeding. Continue to monitor H&H which remain stable.  o Stage IV lung CVA. On immunotherapy outpatient. Per above.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Blood culture negative, Blood folate normal, Blood iron normal, COVID-19 pneumonia, Cerebrovascular accident
Clinical narrative: a 62 y.o. female with a history of shortness of breath and cough has been present for about the last week. Patient states she's felt that for approximately 2 years atrophy diagnosis stage IV lung cancer she states over last week she's had an increased amount of cough congestion short of breath normally wears 2 L at home but has had to turn it up due to shortness of breath has had a lot of wheezing using breathing treatments at home without success cough will not clear she's had no nausea no vomiting but appetite and decreased she has had about a 60 pound weight loss over last 6 months. Denies chest pain bowels have moved without diarrhea patient seen in emergency room noted have bacterial pneumonia as well as Covid pneumonia. Patient follows with oncology for stage IV lung cancer on immunotherapy.  Patient requests dnr code status".   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * Acute on chronic respiratory failure with hypoxia Description of the Problem/Progression:  Plan:  o Pneumonia due to Covid 19 virus with acute respiratory failure with hypoxia. Improving on current treatment. Completed Remdesivir course D5/5.  Continues on IV Solu-Medrol, transitioned to PO tapering course of Prednisone. Weaned oxygen back to oxygen baseline at 2 L. Will taper Decadron to ONCE DAILY. Nebs and inhalers as ordered. Continue to follow up daily inflammatory markers and d-dimer. Continue nebs and inhalers. Encourage incentive spirometry use and pronating. Continue supportive/symptomatic treatment and supplements as ordered per COVID protocol. Follow up daily lab.  o Strep pneumonia bacteremia. Followed by infectious diseases, consult appreciated. Remains on Rocephin. Repeat blood cultures remained no growth at 96 hours. Sputum culture is pending, patient is unable to produce. Status post pleural tap with only 4 cc retrieved. o COPD with acute exacerbation. Improved. Continue nebs, and inhalers, and weaned off IV Solu-Medrol per above. o Pleural effusion. Interventional radiology consulted for possible pleural tap. o Elevated d-dimer. Repeat CTA of the chest shows no pulmonary embolus. However there is evidence of possible spleen hematoma versus other etiologies. Patient is also anemic. Concern about possible splenic hemorrhage versus infarct. Holding anticoagulation. Switched to SCDs for DVT prophylaxis. General surgery consulted. CT of the abdomen and pelvis ordered with IV contrast showing splenic infarct in addition to worsening omental metastasis. Pulmonary consulted palliative care. Patient requested hospice evaluation. She requested discharge home with hospice.   o Anemia with positive occult blood. Workup otherwise is unremarkable for any B12, iron or folate deficiencies. GI consulted. Endoscopy only with overt bleeding. Continue to monitor H&H which remain stable.  o Stage IV lung CVA. On immunotherapy outpatient. Per above.